This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Expert perspectives on biosimilar monoclonal antibodies in breast cancer
Breast Cancer Research and Treatment Open Access 23 February 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carey, K. Biosimilars encircle Rituxan, US debates innovator exclusivity. Nat Biotechnol 29, 177–178 (2011). https://doi.org/10.1038/nbt0311-177
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0311-177
This article is cited by
-
Expert perspectives on biosimilar monoclonal antibodies in breast cancer
Breast Cancer Research and Treatment (2014)
-
Development and Regulation of Biosimilars: Current Status and Future Challenges
BioDrugs (2013)